Not applicableStudy completedNCT02194803
What this trial is testing
Observation of Treatment Patterns With Lucentis in Approved Indications
Who this might be right for
Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
Novartis Pharmaceuticals 5,778